An Exploratory, Multicentre, Double-blind, Double-dummy, Randomised, Parallel-group, Controlled Phase III Study to Evaluate the Safety and Tolerability of Sustained-Release Formulation Quetiapine Fumarate (SEROQUEL) in Treatment of Elderly Subjects with Alzheimers Disease with Symptoms of Psychosis and/or Agitation Compared to Seroquel Immediate Release Formulation.

*Please Note* The Study information you are attempting to view is not available on ClinicalTrials.gov as the Study predates the Food and Drug Administration Amendments Act (FDAAA), Section 801 requirements. More information regarding this study may be available by contacting [email protected].

*Please Note* The Study information you are attempting to view is not available on ClinicalTrials.gov as the Study predates the Food and Drug Administration Amendments Act (FDAAA), Section 801 requirements. More information regarding this study may be available by contacting [email protected].